Senior insider sale
Chief Strategy Officer at JANUX THERAPEUTICS, INC. — senior position signals high conviction
$1.03M
63.13K shares
What this filing means
ROBINSON BYRON plans to sell 63.13K shares of JANUX THERAPEUTICS, INC. valued at approximately $1.03M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/2/2025ACC: 0001950047-25-009650
Officer· Chief Strategy Officer
Since Mar 2022
63.13K
Shares to sell
$1.03M
Approx. market value
63.13K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
12/2/2025
63.13KTotal acquired63.13K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/2/2025 | Stock Option Exercise Cash | 63.13K | — |
| Total | 63.13K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
63.13K
Market value
$1.03M
12/2/2025
Total
Units
63.13K
Value
$1.03M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
12/2/2025 | 63.13K | $1.03M | NASDAQ | Planned |
| Total | 63.13K | $1.03M | ||